Sort
40,608 grants matching “prostate cancer”
DEVELOPMENT OF A FULLY AUTOMATED DEEP LEARNING-BASED FRAMEWORK FOR SEGMENTATION AND TREATMENT RESPONSE ASSESSMENT OF LESIONS ON PSMA PET/CT IN PROSTATE CANCER.
$1,225,783The Regents Of The University Of Colorado · · FY2025 · Defense Health Agency
NEW AWARD - EVALUATING SENESCENT STROMAL FIBROBLASTS AS A PROMOTER OF PROSTATE CANCER LETHALITY TO INFORM A PARADIGM SHIFT IN PROGNOSTIC, PREDICTIVE, AND THERAPEUTIC STRATEGIES...SIGNED 4/9/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/14/2020, FAADC 4/15/2020
$1,225,212The Johns Hopkins University · · FY2020 · Defense Health Agency
Prostate Cancer Studies
$1,224,796Ann Hsing · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
$1,224,416Anant Madabhushi · Emory University · R01 · FY2025 · CA
ROLE OF HOMEOBOX C GENE CLUSTER IN CASTRATION- RESISTANT PROSTATE CANCER.
$1,223,263The Johns Hopkins University · · FY2021 · Defense Health Agency
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$1,223,070Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
General Studies of Epidemiology
$1,222,963Peter Kraft · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Animal Model and Genotyping Core Support Facility
$1,222,900Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Novel Molecular Therapies of Prostate Cancer
$1,222,825Dario C. Altieri · Wistar Institute · P01 · FY2018 · CA
NEW AWARD - THE EFFECT OF ANDROGEN METABOLISM BY GASTROINTESTINAL MICROBIOTA ON RESISTANCE TO ANDROGEN RECEPTOR AXIS-TARGETED THERAPIES IN METASTATIC PROSTATE CANCER, SIGNED 4/17/2020, EFFECTIVE 5/1/2020, DISTRIBUTED 4/20/2020, FAADC 4/20/2020
$1,222,466The Johns Hopkins University · · FY2020 · Defense Health Agency
Pharmacogenetic Studies
$1,222,415Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
The connection of innate and adaptive anti-cancer immunity
$1,221,774John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$1,221,701Diana J Wilkie · University Of Florida · U54 · FY2020 · CA
2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,221,428Clayton Yates · Tuskegee University · U54 · FY2021 · CA
Finding Genes for Human Prostate Cancer
$1,221,136Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2018 · HG
National Black Leadership Initiative on Cancer III: Community Networks Program
$1,220,861Daniel Blumenthal · Morehouse School Of Medicine · U01 · FY2009 · CA
PHASE I SINGLE &MULTIPLE DOSE SAFETY &PHARMACOKINETICS
$1,220,533University Of Illinois At Chicago · N01 · FY2000 · CN
UNDERSTANDING ANTITUMOR T CELL IMMUNITY IN HIGH-RISK LOCALIZED PROSTATE CANCER AFTER NEOADJUVANT TREATMENT WITH AN ANTIBODY TARGETING THE B7-H3 CHECKPOINT
$1,220,281The Johns Hopkins University · · FY2019 · Defense Health Agency
Investigating the role of neutrophils in bone metastasis
$1,220,219Leah Cook · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Plant-based diets and risk of cancer
$1,219,926Gary E. Fraser · Loma Linda University · U01 · FY2011 · CA
Animal Model and Genotyping Core Support Facility
$1,219,865Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
ULTRASOUND IMAGING SYSTEM FOR PROSTATE CANCER
$1,219,510University Of California, Los Angeles · · FY2010 · Department of Defense
NEW AWARD - ROLE OF AR-DERIVED CIRCULAR RNA IN PROSTATE CANCER...SIGNED 30-APR-2020, EFFECTIVE 15 MAY 2020, DISTRIBUTED 5/1/2020, FAADC 5/6/2020
$1,218,950The Johns Hopkins University · · FY2020 · Defense Health Agency
Loma Linda University Center for Health Disparities Research
$1,218,269Marino De Leon · Loma Linda University · P20 · FY2013 · MD
GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE
$1,218,012University Of California, San Diego · · FY2025 · Defense Health Agency